Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-040318
Filing Date
2012-08-03
Accepted
2012-08-03 19:30:28
Documents
1
Period of Report
2012-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3232
  Complete submission text file 0001209191-12-040318.txt   4706
Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Issuer) CIK: 0001012140 (see all company filings)

EIN.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 12790 EL CAMINO REAL C/O NEUROCRINE BIOSCIENCES SAN DIEGO CA 92130
Business Address
WIERENGA WENDALL (Reporting) CIK: 0001235945 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-28298 | Film No.: 121008107